molybdenum has been researched along with Aortic Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frei, B; Leboeuf, RC; McMillen, TS; Wei, H; Zhang, WJ | 1 |
1 other study(ies) available for molybdenum and Aortic Diseases
| Article | Year |
|---|---|
Copper chelation by tetrathiomolybdate inhibits vascular inflammation and atherosclerotic lesion development in apolipoprotein E-deficient mice.
Topics: Animals; Anti-Inflammatory Agents; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Biomarkers; Cell Adhesion Molecules; Ceruloplasmin; Chelating Agents; Copper; Cytokines; Disease Models, Animal; Female; Inflammation; Inflammation Mediators; Iron; Lipids; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Molybdenum; Myocardium | 2012 |